Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
First Letter Of Title
is
O
and
Author
is
Dinardo, Courtney D
[Clear All Filters]
2024
Sasaki K
,
Ravandi F
,
Kadia T
,
Dinardo CD
,
Yilmaz M
,
Short N
,
Jabbour E
,
Patel KP
,
Loghavi S
,
Pierce S
, et al.
Outcome of Patients With Relapsed Acute Promyelocytic Leukemia.
Clin Lymphoma Myeloma Leuk. 2024.
PubMed
Google Scholar
2021
Morita K
,
Kantarjian HM
,
Sasaki K
,
Issa GC
,
Jain N
,
Konopleva M
,
Short NJ
,
Takahashi K
,
Dinardo CD
,
Kadia TM
, et al.
Outcome of patients with chronic myeloid leukemia in lymphoid blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemia treated with hyper-CVAD and dasatinib.
Cancer. 2021.
PubMed
Google Scholar
Venugopal S
,
Shoukier M
,
Konopleva M
,
Dinardo CD
,
Ravandi F
,
Short NJ
,
Andreeff M
,
Borthakur G
,
Daver N
,
Pemmaraju N
, et al.
Outcomes in patients with newly diagnosed TP53-mutated acute myeloid leukemia with or without venetoclax-based therapy.
Cancer. 2021.
PubMed
Google Scholar